Casma Therapeutics
May 03, 2018
Horizon Discovery declines Abcam’s USD 367 million takeover bid
Horizon Discovery declines Abcam’s USD 367 million takeover bid Horizon Discovery has recently rejected a buyout bid worth USD 367 million from Abcam. Horizon Discovery is an expert in gene editing technique and has issued a strong rejection to the offer of Abcam. Horizon’s board believes that the bid unde...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
